The Oncology Institute, Inc. · NASDAQ:TOI
Podnos Yale sold 23,452 The Oncology Institute, Inc. shares (Form 4)
Traded Jul 14, 2026 · Filed Jul 16, 2026
On Jul 14, 2026, Podnos Yale (Chief Medical Officer) sold 23,452 The Oncology Institute, Inc. shares at an average US$6.41 for US$150K under a trading plan, leaving 259,527 shares. Filed Jul 16, 2026 (Form 4).
- Sold
- 23,452 shares
- Price
- US$6.41 average (US$6.35 to US$6.43)
- Value
- US$150K
- Holding after
- 259,527 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Common Stock | Option exercise | 17,974 | US$1.87 | 277,501 | Direct |
| Jul 14, 2026 | Common Stock | Sale | 17,974 | US$6.43 | 259,527 | Direct |
| Jul 14, 2026 | Common Stock | Option exercise | 5,478 | US$2.00 | 265,005 | Direct |
| Jul 14, 2026 | Common Stock | Sale | 5,478 | US$6.35 | 259,527 | Direct |
Source
Related
- The Oncology Institute, Inc.
- Podnos Yale
- The Oncology Institute, Inc. shareholders
- Form 4 · Podnos Yale · Jun 9, 2026
- Form 4 · Podnos Yale · May 22, 2026
- Form 4 · Podnos Yale · Apr 1, 2026
- Form 4 · Kaushal Mohit · Jul 29, 2026
- Form 4 · McGeorge Anne · Jul 29, 2026
- Form 4 · Pacala Mark L · Jul 29, 2026
- Form 4 · Stolper Mark · Jul 29, 2026
- Form 4 · Tzoumakas Kimberly Jo · Jul 29, 2026